Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 USD | +4.76% | -16.24% | +48.65% |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 16 | NexImmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 2.35M |
---|---|---|---|---|---|
Net income 2022 | -62M | Net income 2023 | -32M | EV / Sales 2022 | - |
Net cash position 2022 | 33.62M | Net cash position 2023 | 3.13M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.09
x | P/E ratio 2023 |
-0.07
x | Employees | 50 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.29% |
1 day | +4.76% | ||
1 week | -16.24% | ||
Current month | -41.18% | ||
1 month | -41.07% | ||
3 months | -60.57% | ||
6 months | -26.26% | ||
Current year | +48.65% |
Managers | Title | Age | Since |
---|---|---|---|
Kristi Jones
CEO | Chief Executive Officer | 60 | 17-05-31 |
Mathias Oelke
FOU | Founder | 56 | 11-06-06 |
Tonya Catterton
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Sol Barer
CHM | Chairman | 76 | 19-12-15 |
Zheng Bin Yao
BRD | Director/Board Member | 58 | 16-12-31 |
Alan S. Roemer
BRD | Director/Board Member | 54 | 17-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 3.3 | +4.76% | 6,911 |
24-04-17 | 3.15 | -9.22% | 33,705 |
24-04-16 | 3.47 | -2.25% | 9,291 |
24-04-15 | 3.55 | -1.66% | 26,888 |
24-04-12 | 3.61 | -8.38% | 22,652 |
Delayed Quote Nasdaq, April 18, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+48.65% | 3.73M | |
-3.30% | 102B | |
+1.79% | 96.84B | |
-0.44% | 21.48B | |
-18.35% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
-26.84% | 13.78B | |
+0.59% | 13.4B | |
+20.86% | 11.06B |
- Stock Market
- Equities
- NEXI Stock